Hostname: page-component-77c89778f8-gvh9x Total loading time: 0 Render date: 2024-07-17T01:48:26.410Z Has data issue: false hasContentIssue false

The efficacy of live and inactivated vaccines of Hong Kong influenza virus in an industrial community: A report to the Medical Research Council Committee on Influenza and other respiratory virus vaccines*

Published online by Cambridge University Press:  15 May 2009

D. Hobson
Affiliation:
Department of Medical Microbiology, University of Liverpool
F. A. Baker
Affiliation:
Department of Medical Microbiology, University of Liverpool
R. L. Curry
Affiliation:
Department of Medical Microbiology, University of Liverpool
A. S. Beare
Affiliation:
M.R.C. Common Cold Unit, Salisbury, Wilts.
P. M. O. Massey
Affiliation:
Midland Region Medical Adviser, Central Electricity Generating Board
Rights & Permissions [Opens in a new window]

Extract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Intranasal vaccines of inactivated or living attentuated A2/Hong Kong influenza viruses were compared for clinical acceptability, serological effects and protective efficiency against natural epidemic influenza in a large industrial and clerical population.

Type
Research Article
Copyright
Copyright © Cambridge University Press 1973

References

REFERENCES

Beare, A. S., Hobson, D., Reed, S. E. & Tyrrell, D. A. J. (1968). A comparison of live and killed influenza virus vaccines. Lancet ii, 418.CrossRefGoogle Scholar
Beare, A. S., Tyrrell, D. A. J., Hobson, D., Howells, C. H. L., Pereira, M. S., Pollock, T. M. & Tyler, L. E. (1969). Live influenza B vaccine in volunteers. Journal of Hygiene 67, 1.CrossRefGoogle ScholarPubMed
Hobson, D., Baker, F. A., Chivers, C. P., Reed, S. E. & Sharp, D. (1970). A comparison of monovalent Hong Kong influenza virus vaccine with vaccines containing only pre-1968 Asian strains in adult volunteers. Journal of Hygiene 68, 369.CrossRefGoogle ScholarPubMed
Hobson, D., Curry, R. L., Beare, A. S. & Ward-Gardner, A. (1972). The role of serum haemagglutination-inhibiting antibody in protection against challenge infection with influenza A2 and B viruses. Journal of Hygiene 70, 767.Google ScholarPubMed
Kilbourne, E. D., Schulman, J. L., Schild, G. C., Schloer, G., Swanson, J. & Bucher, D. (1971). Correlated studies of a recombinant influenza virus vaccine. I. Derivation and characterization of virus and vaccine. Journal of Infectious Diseases 124, 449.CrossRefGoogle Scholar
Report (1959). Field trial of influenza virus vaccine in patients with chronic bronchitis during the winter of 1957–58. Report by the joint working party of the Medical Research Council Committee on influenza and other respiratory virus vaccines and of the Research Committee of the British Tuberculosis Association. British Medical Journal ii, 905.Google Scholar
Report (1964). Clinical trials of oil adjuvant influenza vaccines 1960–63. Report to the Medical Research Council by its Committee on Influenza and other respiratory virus vaccines. British Medical Journal 2, 267.Google Scholar
Tyrrell, D. A. J., Buckland, R., Rubenstein, D. & Sharpe, D. M. (1970). Vaccination against Hong Kong influenza in Britain, 1968–69. Journal of Hygiene 68, 359.CrossRefGoogle Scholar
Waldman, R. H. & Coggins, W. J. (1972). Influenza immunization. Field trial on a University campus. Journal of Infectious Diseases 126, 242.CrossRefGoogle ScholarPubMed
Waldman, R. H., Small, P. A. Jr. & Rows, D. S. (1970). The secretory immunologic system (Ed. Dayton, D. H. Jr., Small, P. A. Jr., Chanock, R. M., Kaufman, H. E. and Tomasi, T. B. Jr. U. S. Dept. of Health, Education and Welfare. Public Health Service), p. 129.Google Scholar
World Health Organization (1953). Expert Committee on Influenza. Technical Report Series of the World Health Organization. No. 64.Google Scholar